Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torasemide bolus injection versus continuous infusion in nephrotic syndrome edema
ChiCTR-IPR-15006391Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of torasemide in nephrosis (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoints: Urinary volume, Urinary sodium excretion and 2 more. Started Jun 2015; status: completed.
02
Drugs
torasemide
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR-IPR-15006391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006391.